TYCC
RVMDW icon

Texas Yale Capital Corp’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Texas Yale Capital Corp’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$1.82K – 455
2024
Q1 		$1.82K Hold
10,000
– – ﹤0.01% 447
2023
Q4 		$3.3K Buy
+10,000
New +$4.47K ﹤0.01% 438

Other funds holding RVMDW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Soros Capital Management New York $230M AUM 83.9% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Texas Yale Capital Corp's RVMDW Position: Q2 2024 in Review

Texas Yale Capital Corp sold out of Revolution Medicines Inc Warrant (RVMDW) in Q2 2024, closing a stake of 10,000 shares — an estimated $1.82K sold.

Texas Yale Capital Corp first reported a position in RVMDW in Q4 2023 and held it in 2 quarters. The position peaked at $3.3K in Q4 2023. 25 funds tracked by Wall St. Rank hold RVMDW as of Q2 2024.

  • Texas Yale Capital Corp reported no remaining Revolution Medicines Inc Warrant position as of Q2 2024 after selling out during the quarter.
  • Texas Yale Capital Corp sold 10,000 Revolution Medicines Inc Warrant shares in Q2 2024, an estimated $1.82K.
  • Texas Yale Capital Corp first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and held it in 2 quarters.
  • Texas Yale Capital Corp's Revolution Medicines Inc Warrant position peaked at $3.3K in Q4 2023.
  • 25 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2024.

Based on Texas Yale Capital Corp's 13F filing for Q2 2024, filed 13 Aug 2024.